Substance Use Disorders and Anesthesia Management - On Demand Access
-
You must log in to register
- Member - Free!
- Resident Member - Free!
- Allied Staff Member - Free!
- Professional Staff Nonmember - $150
- Other Nonmember - $150
The Medication Access and Training Expansion (MATE) Act requires practitioners to meet specific training requirements tied to their initial or renewal DEA registration. This 90-minute webinar – which appears to fulfill 1.5 hours of the eight-hour requirement of the MATE Act – provides training on how to treat and manage patients with opioid or other substance use disorders (SUDs), including use of drugs approved by the FDA for the treatment of a substance use disorder. The webinar will address safe pharmacological management of dental pain and screening, brief intervention, and referral for appropriate treatment of patients with, or at risk of developing, opioid or other substance use disorders. The potential clinical implications of patients with SUDs also will be discussed.
Learning Objectives
At the conclusion of this program, participants should be able to:
- Discuss the current definition of a SUD.
- Examine the current statistics of SUDs in the U.S.
- Analyze the top four substances of misuse in the U.S. and explain how they impact anesthesia.
- Evaluate the use of buprenorphine.
- Determine special considerations agreements when prescribing opioids.
An Internet-based CDE/CME Activity
Original Release Date: June 21, 2023
Expiration Date: June 21, 2026
Estimated time to complete this educational activity: 1.5 hours
Method of participation: Self-Study
P. Angela Rake, DDS
Dr. Rake completed her dental training at the University of Minnesota School of Dentistry. She completed an oral and maxillofacial surgery internship at the Minneapolis Veterans Affairs Medical Center. She is a graduate of the oral and maxillofacial surgery advanced training program at the University of Minnesota.
In 2002, Dr. Rake joined Dakota Valley Oral and Maxillofacial Surgery. She remains active as Adjunct Associate Professor in the Division of Oral and Maxillofacial Surgery at the University of Minnesota School of Dentistry. She lectures on numerous topics locally and nationally. She has gained national attention for safe and responsible opioid prescribing and office-based anesthesia. She has been featured in The New York Times, Washington Post, NBC Universal and local media outlets.
She is a Diplomate of ABOMS and a member of the AAOMS, ADSA, ADA, Minnesota Dental Association and Minneapolis District Dental Society.
She is past President of the Minnesota Society of Oral and Maxillofacial Surgery. Currently, she serves on the Clinical Governance Board with US Oral Surgery Management, a NIH-NIDAMED Contracted Panelist and an appointed member and President of the Minnesota Board of Dentistry.
Disclosures: No relevant financial relationships were disclosed.
Continuing Education Provider Approval
The American Association of Oral and Maxillofacial Surgeons is an ADA CERP Recognized Provider.
ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education.
ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry.
The American Association of Oral and Maxillofacial Surgeons designates this activity for 1.5 continuing education credit(s).
AGD - Accepted Program Provider
FAGD/MAGD Credit
11/1/22-12/31/26
Provider ID# 214680
The American Association of Oral and Maxillofacial Surgeons (AAOMS) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American Association of Oral and Maxillofacial Surgeons designates this internet-based enduring material for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Key:
Complete
Next
Failed
Available
Locked